Opus Genetics, Inc.
(NASDAQ: IRD)
Opus Genetics, Inc. engages in the research and development of ophthalmic biopharmaceutical products. It focuses on developing and commercializing therapies for the treatment of several eye disorders. The company was founded by Mina Patel Soouch and Alan R. Meyer in February 2018 and is headquartered in Durham, NC.
2.540 -
-0.160
(-5.93%)
Range
2.490 - 2.724
(9.40%)
Open
2.700
Previous Close
2.700
Bid Price
2.530
Bid Volume
627
Ask Price
2.540
Ask Volume
600
Volume
458,023
Value
830,702
Remark
-
Delayed prices. Updated at 30 Jan 2026 01:40.
Data powered by
View All Events
Loading Chart...
Please login to view stock data and analysis
